360 filings
Page 12 of 18
8-K
hqxtzgaarq6qd6td
22 Jul 11
Other Events
12:00am
8-K
l5tmhc91o7x50z 9gg0
20 Jul 11
Dynavax Reports Second Quarter 2011 Financial Results
12:00am
8-K
toz802yse 1vqwzlbksf
3 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
p64xloflh09vrsr66
25 May 11
Data Expected within Eight Weeks
12:00am
8-K
znet46m in1hz1xs
19 May 11
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
zhmxxtqszu5lr6z98
5 May 11
Dynavax Reports First Quarter 2011 Financial Results
12:00am
8-K
qmmhxsfg1sr
20 Apr 11
Other Events
12:00am
8-K
ie898
9 Mar 11
Dynavax Reports Fourth Quarter and Year End 2010 Financial Results
12:00am
8-K
g25giz
24 Feb 11
Dynavax Reports New Phase 1A and Phase 1B Data for Universal Flu Vaccine Candidate
12:00am
8-K
1cr 9kib597q
10 Jan 11
Dynavax Completes Enrollment for Phase 3 Study of Heplisav(tm) In Subjects with Chronic Kidney Disease
12:00am
8-K
wcww8
7 Jan 11
Departure of Directors or Certain Officers
12:00am
8-K
5bp7q1 ljb
5 Jan 11
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
bdgwk
23 Dec 10
Other Events
12:00am
8-K
d0xmcp zi56iyyp
7 Dec 10
Dynavax Reports Phase 1A Safety and Immunogenicity Results for Universal Flu Vaccine
12:00am
8-K
aamk2
23 Nov 10
Departure of Directors or Certain Officers
12:00am
8-K
y85 jkb0e6hi
8 Nov 10
Dynavax Reports 2010 Third Quarter Financial Results
12:00am
8-K
iqsiycfqi8j
28 Oct 10
Dynavax Announces Proposed Public Offering of Common Stock
12:00am
8-K
nar90l7evx v4kte
27 Oct 10
Results of Operations and Financial Condition
12:00am
8-K
d6rx0bd
13 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
9x0c2tjs8ffs8do 8e9i
4 Oct 10
Other Events
12:00am